Lifestyle intervention and fatty acid metabolism in glucose-intolerant subjects

Obesity Research

Volumn 13, Issue 8, 2005, Pages 1354-1362

  Mensink, Marco ^a   Blaak, Ellen E ^a   Wagenmakers, Anton J ^a   Saris, Wim H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fatty acid metabolism; Impaired glucose tolerance; Lifestyle intervention; Stable isotopes; Type 2 diabetes

Indexed keywords

FATTY ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; ENERGY METABOLISM; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; KINESIOTHERAPY; LIFESTYLE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EXERCISE THERAPY; FATTY ACIDS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 32944456811     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.164     Document Type: Article

References (37)

1. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992;258:766-70.
2. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.
3. Colberg SR, Simoneau JA, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest. 1995;95:1846-53.
4. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:2349-56.
5. Blaak EE, Wagenmakers AJ, Glatz JF, et al. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab. 2000;279:E146-54.
6. Blaak EE, van Aggel-Leijssen DPC, Wagenmakers AJM, Saris WHM, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes. 2000;49:2102-7.
7. Pan DA, Lillioja S, Kriketos AD, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997;46:983-8.
8. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes. 2001;50:2337-43.
9. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab. 2001;86:1638-44.
10. Turpeinen AK, Takala TO, Nuutila P, et al. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes. 1999;48:1245-50.
11. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes. 2001;50:2548-54.
12. Schrauwen P, Van Aggel-Leijssen DP, Hul G, et al. The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes. 2002;51:2220-6.
13. Sial S, Coggan AR, Hickner RC, Klein S. Training-induced alterations in fat and carbohydrate metabolism during exercise in elderly subjects. Am J Physiol. 1998;274:E785-90.
14. Van Aggel-Leijssen DP, Saris WH, Wagenmakers AJ, Senden JM, Van Baak MA. Effect of exercise training at different intensities on fat metabolism of obese men. J Appl Physiol. 2002;92:1300-9.
15. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
16. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
17. Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE. Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord. 2003;27:377-84.
18. Mensink M, Corpeleijn E, Feskens EJ, et al. Study on lifestyle- intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Res Clin Pract. 2003;61:49-58.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
20. Siri W. The gross composition of the body. Adv Biol Med Phys. 1956;4:239-80.
21. 2 background enrichment during exercise: diet-related differences between Europe and America. J Appl Physiol. 1993;74:2353-7.
22. Schrauwen P, Blaak EE, Van Aggel-Leijssen DP, Borghouts LB, Wagenmakers AJ. Determinants of the acetate recovery factor: implications for estimation of [13C]substrate oxidation. Clin Sci (Lond). 2000;98:587-92.
23. Weir J. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109:1-9.
24. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol. 1983;55:628-34.
25. Jeukendrup AE, Raben A, Gijsen A, et al. Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol. 1999;515:579-89.
26. Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR. A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol. 1995;269:E649-56.
27. Schrauwen P, Wagenmakers AJ, van Marken Lichtenbelt WD, Saris WH, Westerterp KR. Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes. 2000;49:640-6.
28. Kanaley JA, Cryer PE, Jensen MD. Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energy-restricted diet. J Clin lnvest. 1993;92:255-61.
29. Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol. 1996;81:2027-33.
30. Horowitz JF, Klein S. Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. J Appl Physiol. 2000;89:2276-82.
31. Mensink M, Blaak EE, Vidai H, De Bruin TW, Glatz JF, Saris WH. Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance. Diaberologia. 2003;46:1082-9.
32. Jones PJ, Schoeller DA. Polyunsaturated:saturated ratio of diet fat influences energy substrate utilization in the human. Metabolism. 1988;37:145-51.
33. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol. 1999;276:E1-18.
34. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol. 1984;56:831-8.
35. Kiens B, Essen-Gustavsson B, Christensen NJ, Saltin B. Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. J Physiol. 1993;469:459-78.
36. Kiens B. Effect of endurance training on fatty acid metabolism: local adaptations. Med Sci Sports Exerc. 1997;29:640-5.
37. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 1999;13:2051-60.